- Previous Close
9,410.00 - Open
9,470.00 - Bid 9,580.00 x --
- Ask 10,290.00 x --
- Day's Range
9,420.00 - 9,600.00 - 52 Week Range
9,030.00 - 12,700.00 - Volume
1,630 - Avg. Volume
2,012 - Market Cap (intraday)
34.823B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield 120.00 (1.25%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
--
Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.
www.yuyu.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 000227.KS
View MorePerformance Overview: 000227.KS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 000227.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 000227.KS
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
6.55%
Return on Assets (ttm)
3.88%
Return on Equity (ttm)
8.06%
Revenue (ttm)
133.15B
Net Income Avi to Common (ttm)
8.72B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
42.65B
Total Debt/Equity (mrq)
24.91%
Levered Free Cash Flow (ttm)
21.17B